The evolving frontier of diabetes therapy: The renaissance of glycemology

Area of Science:

• Endocrinology
• Metabolic Diseases
• Cardiovascular Risk Management

Background:

• Historically, diabetes was conceptualized as a cardiovascular disease, with hypertension and dyslipidemia control prioritized over hyperglycemia.
• The focus on glycemic control waned as evidence suggested limited benefits from solely targeting hyperglycemia.
• Glycemic control was primarily measured by glycated hemoglobin (HbA1c), reflecting average blood glucose over 2-3 months.

Purpose of the Study:

• To re-evaluate the concept of glycemic control in diabetes management.
• To highlight the evolving understanding of hyperglycemia beyond HbA1c levels.
• To propose a modern, multifaceted approach to optimizing glycemic control.

Main Methods:

• Review of existing evidence on diabetes management and cardiovascular risk.
• Analysis of the limitations of traditional HbA1c-centric glycemic control.
• Incorporation of recent findings on different aspects of hyperglycemia.

Main Results:

• The concept of diabetes as solely a cardiovascular disease is outdated.
• Hyperglycemia is now understood to have various forms and aspects.
• Optimal glycemic control requires a broader strategy than just achieving target HbA1c.

Conclusions:

• A modern approach to diabetes care must integrate HbA1c targets with management of postprandial hyperglycemia and glycemic variability.
• Avoiding hypoglycemia is a critical component of contemporary glycemic control.
• This updated strategy aims for better patient outcomes and reduced complications.